Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers
Clinical Pharmacology & Therapeutics · 2026-09 · 120 (3) · 795-805
DOI: 10.1002/cpt.70379 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 14.07.2026. Verfasst von Sidharth Anand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Fomepizole, Acetaminophen, Cytochrome P-450 CYP2E1 Inhibitors, Analgesics, Non-Narcotic. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acetaminophen overdose can cause liver injury. Hepatotoxicity results from N ‐acetyl‐ p ‐benzoquinone imine (NAPQI), generated via cytochrome P450‐2E1 (CYP2E1). Acetylcysteine is the mainstay of treatment, but efficacy may be reduced with delayed administration or large ingestions. Fomepizole, a CYP2E1 inhibitor, reduces NAPQI when co‐administered with acetaminophen, but its clinical relevance remains uncertain. The objective was to evaluate the effect of fomepizole administered 2 hours after acetaminophen ingestion in immediate‐ and modified‐release overdose. In a randomized crossover study simulating overdose, healthy volunteers received ~≈80 mg/kg of either immediate‐ or modified‐release acetaminophen followed by intravenous fomepizole or placebo 2 hours later. Volunteers crossed over after 2 weeks. Urine and serum were collected over 24 hours to measure acetaminophen, non‐toxic metabolites (APAP‐Glu, APAP‐Sul), and NAPQI metabolites (APAP‐Mer, APAP‐Cys). The primary outcome was the proportion of NAPQI metabolites in urine relative to total excreted compounds. Secondary outcomes included 24‐hour AUCs for metabolites. Five crossover pairs were completed per formulation. Median 24‐hour urinary recovery was 92% (IQR: 89–95%). Fomepizole significantly reduced the mean percentage of urinary NAPQI metabolites for both immediate‐release (4.92% [SD: 0.97] vs. 1.72% [SD: 0.3], mean difference [fomepizole–control]: ‐3.20%, 95% CI: −4.45 to −1.95%, P = 0.0021) and modified release acetaminophen (5.62% [SD: 1.1] vs. 1.43% [SD: 0.3], mean difference [fomepizole–control]: −4.19%, 95% CI: −5.23 to −3.15%, P = 0.0004). Mean serum NAPQI metabolite AUCs were lower with fomepizole: 89.3 [SD: 11.1] vs. 32.5 [SD: 3.3] μmol/L*h (mean difference [fomepizole–control]: −56.8, 95% CI: −72.6 to −41.0, P =0.0006) for immediate‐release, and 96.7 [SD: 15.2] vs. 27.2 [SD:7.2] μmol/L*h (mean difference [fomepizole–control]: −69.5, 95% CI:–84.6 to −54.4, P = 0.0002) for modified‐release acetaminophen. Fomepizole, administered 2 hours after an acetaminophen overdose, reduced NAPQI formation by 60–70%, supporting further evaluation as an adjunct in overdoses where acetylcysteine may be insufficient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
- NSW Health Pathology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
- Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Acetaminophen Toxicity Diagnostics, LLC, Little Rock, Arkansas, USA.
- Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
ORCID-Profile: Nicholas A Buckley, Mitchell R McGill, Angela L Chiew
Zitieren
APA
Anand, S., Buckley, N. A., Stathakis, P., James, L., Parker, L., McGill, M. R., & Chiew, A. L. (2026). Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers. Clinical Pharmacology & Therapeutics, 120(3), 795-805. https://doi.org/10.1002/cpt.70379
Vancouver
Anand S, Buckley NA, Stathakis P, James L, Parker L, McGill MR, et al. Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers. Clinical Pharmacology & Therapeutics. 2026;120(3):795-805. doi:10.1002/cpt.70379
BibTeX
@article{Anand2026,
author = {Anand, Sidharth and Buckley, Nicholas A and Stathakis, Paul and James, Laura and Parker, Larry and McGill, Mitchell R and Chiew, Angela L},
title = {Effects of Fomepizole on Acetaminophen Oxidative Metabolism: A Randomized, Crossover Study in Human Volunteers},
journal = {Clinical Pharmacology & Therapeutics},
year = {2026},
volume = {120},
number = {3},
pages = {795--805},
doi = {10.1002/cpt.70379}
}
EUVIMED